Skip to main content

Advertisement

Table 5 A summary of the dosimetric parameters for \(\mathbb {P}^{\text {WH}}\), \(\mathbb {P}^{\text {WF}}\) and \(\mathbb {P}^{\text {RF}}\) plans for a single patient

From: Radiomics based targeted radiotherapy planning (Rad-TRaP): a computational framework for prostate cancer treatment planning with MRI

Parameter Whole gland homogeneous (\(\mathbb {P}^{\text {WH}}\)) Whole gland with focal boost (\(\mathbb {P}^{\text {WF}}\)) Focal (\(\mathbb {P}^{\text {RF}}\)) (\(\mathbb {P}^{\text {WF}}- \mathbb {P}^{\text {WH}}\)) (\(\mathbb {P}^{\text {RF}}-\mathbb {P}^{\text {WH}}\))
Prostate
V 100 % 99.6 99.32 94.21 -0.28 -5.39
D 98 Gy. 80.2 79.6 85.2 -0.6 5
D min (0.03 cc.) Gy. 76.7 78.5 83.8 1.8 7.1
D max (0.03 cc.) Gy. 81.9 102.5 91.3 20.6 9.4
Mean Dose Gy. 80.8 84.09 87.9 3.29 7.1
Bladder
V 15% Gy. 60.7 65.5 1.45 4.8 -59.25
V 25% Gy. 46.9 51.7 1.85 4.8 -45.05
V 35% Gy. 36.1 42.6 1.67 6.5 -34.43
V 50% Gy. 24.1 33 1.45 8.9 -22.65
Rectum
V 15% Gy. 63.7 60 10.5 -3.7 -53.2
V 25% Gy. 50.8 50.2 4.35 -0.6 -46.45
V 35% Gy. 36.5 42.8 2.65 6.3 -33.85
V 50% Gy. 23.2 27 1.9 3.8 -21.3
Penile bulb
Mean Dose Gy. 48.98 61.97 3.65 12.99 -45.33
L. Femoral Head
Mean Dose Gy. 22.1 23.3 2.3 1.2 -19.8
R. Femoral Head
Mean Dose Gy. 19.8 21.3 1.4 1.5 -18.4
  1. It can be observed that the \(\mathbb {P}^{\text {RF}}\) resulted in significant reduction in the dosage to surrounding regions including bladder, rectum, penile bulb and the femoral heads (highlighted in bold-face)